[1] Tatar M, Shoorekchali JM, Faraji MR, Wilson FA. International COVID-19 vaccine inequality amid the pandemic: perpetuating a global crisis? J Glob Health 2021;11:03086. http://dx.doi.org/10.7189/jogh.11.03086.
[2] Chen ZY, Zheng W, Wu QH, Chen XH, Peng C, Tian YY, et al. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study. BMC Med 2022;20(1):130. https://doi.org/10.1186/s12916-022-02333-0CrossRef
[3] Liu F, Zhao ZB, Ma CF, Nie XW, Wu AD, Li X. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants. Epidemiol Infect 2022;150:e46. https://doi.org/10.1017/S0950268822000139CrossRef
[4] Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 2021;397(10278):1023 − 34. https://doi.org/10.1016/S0140-6736(21)00306-8CrossRef
[5] Ning CL, Wang H, Wu J, Chen QW, Pei HC, Gao H. The COVID-19 vaccination and vaccine inequity worldwide: an empirical study based on global data. Int J Environ Res Public Health 2022;19(9):5267. https://doi.org/10.3390/ijerph19095267CrossRef
[6] Bargain O, Aminjonov U. Trust and compliance to public health policies in times of COVID-19. J Public Econ 2020;192:104316. https://doi.org/10.1016/j.jpubeco.2020.104316CrossRef
[7] Falkenbach M, Willison C. Resources or trust: what matters more in the vaccination strategies of high-income liberal democracies? Health Policy Technol 2022;11(2):100618. http://dx.doi.org/10.1016/j.hlpt.2022.100618.
[8] Sachs JD, Karim SSA, Aknin L, Allen J, Brosbøl K, Colombo F, et al. The lancet commission on lessons for the future from the COVID-19 pandemic. Lancet 2022;400(10359):1224 − 80. https://doi.org/10.1016/S0140-6736(22)01585-9CrossRef
[9] Momeni Y. Gavi’s strategy to support African regional manufacturing. 2023. https://www.unicef.org/supply/media/19216/file/UNICEF-VIC2023-Session12-AVMAUpdate-Gavi-2023.pdf. [2023-11-15].
[10] Nuzzo JB, Gostin LO. The first 2 years of COVID-19: lessons to improve preparedness for the next pandemic. JAMA 2022;327(3):217 − 8. https://doi.org/10.1001/jama.2021.24394CrossRef
[11] Hatala A, Pervaiz MC, Handley R, Vijayan T. Faith based dialogue can tackle vaccine hesitancy and build trust. BMJ 2022;376:o823. https://doi.org/10.1136/bmj.o823CrossRef
[12] Anakpo G, Mishi S. Hesitancy of COVID-19 vaccines: rapid systematic review of the measurement, predictors, and preventive strategies. Hum Vaccin Immunother 2022;18(5):2074716. https://doi.org/10.1080/21645515.2022.2074716CrossRef